Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

Annals of Neurology

Volumn 41, Issue 6, 1997, Pages 789-796

  Gajdos, Philippe ^a,d   Chevret, Sylvie ^b   Clair, Bernard ^a   Tranchant, Christine ^c   Chastang, Claude ^b  

^a Serv de Reanimation Med   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Service de Neurologie   (France)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMBENONIUM; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE; PYRIDOSTIGMINE;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERANCE; FEMALE; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MUSCLES; MYASTHENIA GRAVIS; PLASMA EXCHANGE; RECEPTORS, CHOLINERGIC;

EID: 0031001759     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410615     Document Type: Article

References (19)

1. Imbach P, Barundun S, d'Apuzzo U, et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-1231
2. Dwyers JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-116
3. Gajdos P, Outin HD, Elkharrat D, et al. High dose intravenous gamma globulin for myasthenia gravis. Lancet 1984;1: 406-407 (Letter)
4. Fateh-Moghadam A, Wick M, Besinger U, Geursen RG. High dose intravenous gamma globulin for myasthenia gravis. Lancet 1984;1:848-849
5. Arsura E, Bick A, Brunner NG, et al. High dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Int Med 1986;146:1365-1368
6. Gajdos P, Outin HD, Morel E, et al. High dose intravenous gamma globulin for myasthenia gravis: an alternative to plasma exchange. Ann NY Acad Sci 1987;505:842-844
7. Arsura R. Experience with intravenous immunoglobulin in myasthenia gravis. Clin Immunol Immunopathol 1989;53:S170-S179
8. Bergamini L, Cocito D, Durelli L, Quattrololo G. Opinions about plasma exchange and associated treatment in myasthenia gravis. Muscle Nerve 1983;6:457-458
9. Bouget J, Chevret S, Chastang C, et al. Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. Grit Care Med 1993; 21:651-658
10. Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;1:703-707
11. Godeau B, Lesage S, Divine M, et al. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high dose intravenous immunoglobulin. Blood 1993;82:1415-1421
12. Gajdos P, Elkharrat D, Chevret S, Chastang C. A randomized clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J Neurol Neurosurg Psychiatry 1993;56:1157-1163
13. Cosi V, Lombardi M, Piccolo G, Erbetta A. Treatment of myasthenia gravis with high dose intravenous immunoglobulin. Acta Neurol Scand 1991;84:81-84
14. Seybold ME. Plasmapheresis in myasthenia gravis. Ann NY Acad Sci 1987;505:584-587
15. Fornasari PM, Riva G, Piccolo G, et al. Short and long term clinical effects of plasma exchange in 33 cases of myasthenia gravis. Int J Artific Organs 1985;8:159-162
16. Antozzi C, Gemma M, Regi B, et al. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 1991; 238:103-107
17. NIH Consensus Conference. Intravenous immunoglobulin. Prevention and treatment of disease. JAMA 1990;264:3189-3193
18. Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137-139
19. Watson JDG, Gibson J, Joshul DE, Kornemberg H. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry 1991;54:275-276